Ursal, Jayver .

HRN: 24-70-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
CEFTRIAXONE 1G (VIAL)
03/22/2024
03/28/2024
IV DRIP
1gm
Q12
Orchitis, T/C Complicated UTI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: